Oxytet Soluble

Hazard statements (CLP)

H319, H360

Code

Statements

H319

Causes serious eye irritation

SECTION 2: Hazards identification

OSHA Appearance: Yellow powder

2.1 Classification of the substance or mixture

Reproductive Toxicity: Category 1A Skin corrosion/irritation: Category 2 Serious eye damage/eye irritation: Category 2A Specific target organ toxicity, single exposure: Category 3 respiratory tract irritation US OSHA Specific - Classification Emergency telephone number:1-877-994-4883 Contact e-mail: customerservice@huvepharma.us

Physical hazards

Combustible Dust

Signal word

Danger

Hazard statements

H319- Causes serious eye damage H360 - May damage fertility or the unborn child May form combustible dust concentrations in air

Precautionary statements

P210 - Keep away from heat/sparks/open flames/hot surfaces. - No smoking P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 - IF exposed or concerned: Get medical attention/advice P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations

2.3 Other hazards

Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on male reproductive system, liver, the developing fetus. Known Clinical Effects: May cause effects similar to those seen in clinical use including transient diarrhea, nausea and abdominal pain. Symptoms of chronic exposure to tetracyclines include redness and swelling of the skin, rash, chills, tooth discoloration, yellowing of the skin and eyes, nausea, vomiting, diarrhea, stomach pain, and chest pain. Individuals sensitive to this material or other materials in its chemical class may develop allergic reactions. Wheezing, asthma, low or high blood pressure, dizziness, lung congestion, blood changes (leukocytosis, atypical lymphocytes, toxic granulation of granulocytes and thrombocytopenia purpura), convulsion or shock may also occur. Clinical use of this drug has caused liver effects, kidney dysfunction. Note: This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.